bioAffinity Technologies, Inc. Loans Payable, Current
bioAffinity Technologies, Inc. (BIAF) had Loans Payable, Current of $42.33 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2024-04-01
- 2023-06-30: Loans Payable, Current $42.33K.
- 2023-03-31: Loans Payable, Current $168.43K.
- 2022-12-31: Loans Payable, Current $251.75K.
- 2022-09-30: Loans Payable, Current $490.12K.
| Period end | Loans Payable, Current |
|---|---|
| 2023-06-30 | $42.33K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $168.43K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $251.75K 10-K · filed 2024-04-01 |
| 2022-09-30 | $490.12K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |